CD19-CAR_Lenti T cells / Bambino Gesu Hospital - LARVOL DELTA

CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML (clinicaltrials.gov) - P1/2 | N=32 | Active, not recruiting | Sponsor: Bambino Gesù Hospital and Research Institute | Recruiting ➔ Active, not recruiting | Trial primary completion date: Mar 2025 ➔ Mar 2027

Enrollment closed • Trial primary completion date • Acute Lymphocytic Leukemia • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Leukemia • Lymphoma • Mediastinal B Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • Pediatrics • Primary Mediastinal Large B-Cell Lymphoma • CD19 • PBX1 • TCF3 • TP53